Listen

Add to my selection

VYNDAQEL

Medicine - Posted on Oct 16 2020 - Updated on Oct 16 2020

Active substance (DCI)

tafamidis

history (3)

9/23/20

VYNDAQEL

Key points Favourable opinion for reimbursement in adult patients with wild-type or hereditary transthyretin amyloid cardiom...

CAV :
54321

icône flèche
10/23/19

VYNDAQEL (tafamidis)

L’essentiel Avis favorable au maintien du remboursement dans l’indication de l’AMM. Service médical rendu désormais importan...

CAV :
54321

icône flèche
4/11/12

VYNDAQEL

-

CAV :
54321

icône flèche

Technical information

ATC code

N07XX08

Manufacturer

PFIZER

Presentation

VYNDAQEL 20 mg, capsule molle
2 plaquette(s) PVC-Aluminium de 15 capsule(s) (CIP : 34009 218 245 9 9)

VYNDAQEL 61 mg, capsule molle
2 plaquette(s) PVC-Aluminium de 15 capsule(s) (CIP : 34009 302 020 7 4)

All our publications

Congenital, genetic and rare diseases

Metabolic diseases

Nervous system diseases - miscellaneous